“A new vaccine against the most deadly forms of pneumonia, one of the world’s biggest killers of children, [was] launched in Nicaragua [on Sunday] as part of an effort to prevent 700,000…
Tag: virus
Methodist Willowbrook Hospital achieves zero infection rate in top three at-risk categories
In a rare feat for any hospital in the United States, Methodist Willowbrook Hospital in Houston has not recorded a hospital-acquired infection in the top three at-risk areas for 14 consecutive months….
Human-networking theory to count number of possible disease-spreading events
It’s colds and flu season, and as any parent knows, colds and flu spread like wildfire, especially through schools. New research using human-networking theory may give a clearer picture of just how,…
Clinical trail shows 2009 H1N1 influenza vaccine safe and effective in asthma patients
Results from a government-sponsored clinical trial of inactivated 2009 H1N1 influenza vaccine in people with asthma indicate that a single dose of vaccine was safe and induced a strong immune response predictive…
New collaboration to develop vaccine to prevent malaria parasite from entering human liver
Researchers seek to block activity of key protein in order to stop malaria parasite from entering the liver Development of a vaccine to prevent the malaria parasite from entering the human liver…
Researchers implements life skills program to South African youth for drug abuse and risky sexual behavior
Drug use, risky sexual behavior and violence among South African youth may be reduced thanks to Penn State researchers, who will look at expanding a leisure education and life skills program to…
PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing…
New DNA-based testing technology for tuberculosis treatment
The driving force behind the rapid tuberculosis test that received World Health Organization endorsement this week is Dr. David Alland, chief of the Division of Infectious Disease at UMDNJ-New Jersey Medical School….
New groundbreaking research advances understanding of HIV
It is estimated that 38 million people worldwide are currently infected with HIV and that 4.1 million more are added each year. For scientists to design treatment therapies that are effective over…
Cholera Strain Evolves New Mechanism For Causing Disease
New clinical strains of cholera appear to have evolved a distinctly different mechanism to cause the same disease according to research published in the current issue of the online journal mBio®. Vibrio…
Haiti Cholera Strain Matches Bacteria From South Asia
A team of researchers from Harvard Medical School, Brigham and Women’s Hospital, and Massachusetts General Hospital, with others from the United States and Haiti, has determined that the strain of cholera erupting…
Study Suggests Cranberry Juice Not Effective Against Urinary Tract Infections
Drinking cranberry juice has been recommended to decrease the incidence of urinary tract infections, based on observational studies and a few small clinical trials. However, a new study published in the January…
Automated UV-C Device Reduces Infectious Pathogens In Hospital Patient Rooms By More Than 99.9% In Only 15 Minutes
Results of an eight-month hospital study, “Room Decontamination with UV Radiation,” were published in the October 2010 issue of “Infection Control and Hospital Epidemiology.” The study evaluated the ability of an automated…
GeoVax’s phase 2a trial results indicate excellent safety profile for HIV vaccine
GeoVax Labs, Inc., announced today that early results from part A of an ongoing phase 2a clinical trial indicate an excellent safety profile and highly reproducible immunogenicity. The phase 2a trial is…
Haitian cholera pathogen closely related to ‘El Tor O1’ variant from South Asia
Scientists from Pacific Biosciences of California, Inc. (NASDAQ:PACB) and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly…